{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:30:18Z","timestamp":1785817818839,"version":"3.56.0"},"reference-count":34,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"unspecified","delay-in-days":21,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Laryngol. Otol."],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S002221512100013X_sec_a1\"><jats:title>Objective<\/jats:title><jats:p>This study aimed to compare antibiotic treatment with clindamycin versus penicillin V or G in terms of time to recovery and recurrence in patients with peritonsillar infection, including both peritonsillar cellulitis and peritonsillar abscess.<\/jats:p><\/jats:sec><jats:sec id=\"S002221512100013X_sec_a2\" sec-type=\"methods\"><jats:title>Method<\/jats:title><jats:p>This retrospective cohort study examined the records of 296 patients diagnosed with peritonsillar infection. Based on the ENT doctor's choice of antibiotics, patients were divided into clindamycin and penicillin groups.<\/jats:p><\/jats:sec><jats:sec id=\"S002221512100013X_sec_a3\" sec-type=\"results\"><jats:title>Results<\/jats:title><jats:p>Mean number of days in follow up was 3.5 days in the clindamycin group and 3.4 days in the penicillin group. The recurrence rate within 2 months was 7 per cent in the clindamycin group and 4 per cent in the penicillin group.<\/jats:p><\/jats:sec><jats:sec id=\"S002221512100013X_sec_a4\" sec-type=\"conclusions\"><jats:title>Conclusion<\/jats:title><jats:p>This study found no significant differences in either recovery or recurrence between the groups. This supports the use of penicillin as a first-line treatment, considering the greater frequency of adverse effects of clindamycin shown in previous studies, as well as its profound collateral damage on the intestinal microbiota, resulting in antibiotic resistance.<\/jats:p><\/jats:sec>","DOI":"10.1017\/s002221512100013x","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T03:47:54Z","timestamp":1611287274000},"page":"64-69","source":"Crossref","is-referenced-by-count":6,"title":["Antibiotics in treatment of peritonsillar infection: clindamycin versus penicillin"],"prefix":"10.1017","volume":"135","author":[{"given":"F","family":"Hallgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Lindell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Nilsson-Helger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Lundqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2021,1,22]]},"reference":[{"key":"S002221512100013X_ref18","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001442"},{"key":"S002221512100013X_ref30","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv115"},{"key":"S002221512100013X_ref16","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw038"},{"key":"S002221512100013X_ref15","doi-asserted-by":"publisher","DOI":"10.1007\/BF01643477"},{"key":"S002221512100013X_ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1981.tb06235.x"},{"key":"S002221512100013X_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0194-5998(99)70370-0"},{"key":"S002221512100013X_ref13","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215108004106"},{"key":"S002221512100013X_ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-010-1130-9"},{"key":"S002221512100013X_ref33","unstructured":"33 STRAMA. The Swedish strategic programme against antibiotic resistance: antibiotic treatment recommendations. In: http:\/\/strama.se\/behandlingsrekommendationer\/2019 [30 July 2020]"},{"key":"S002221512100013X_ref4","doi-asserted-by":"publisher","DOI":"10.3109\/00016489.2014.905702"},{"key":"S002221512100013X_ref14","unstructured":"14 Fairbanks, DNF . Pocket guide to antimicrobial therapy in otolaryngology-head and neck surgery, 13th edn. In: https:\/\/www.entnet.org\/content\/pocket-guide-antimicrobial-therapy-otolaryngology [30 July 2020]"},{"key":"S002221512100013X_ref21","first-page":"5","article-title":"The epidemiology, antibiotic resistance and post-discharge course of peritonsillar abscesses in London, Ontario","volume":"42","author":"Sowerby","year":"2013","journal-title":"J Otolaryngol"},{"key":"S002221512100013X_ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-4486.2012.02452.x"},{"key":"S002221512100013X_ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2019.10.008"},{"key":"S002221512100013X_ref12","first-page":"B5333","article-title":"Peritonsillar abscess: clinical aspects of microbiology, risk factors, and the association with parapharyngeal abscess","volume":"64","author":"Klug","year":"2017","journal-title":"Dan Med J"},{"key":"S002221512100013X_ref10","doi-asserted-by":"publisher","DOI":"10.31729\/jnma.145"},{"key":"S002221512100013X_ref25","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ137"},{"key":"S002221512100013X_ref2","doi-asserted-by":"publisher","DOI":"10.1080\/00365540802195226"},{"key":"S002221512100013X_ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2015.10.008"},{"key":"S002221512100013X_ref24","doi-asserted-by":"publisher","DOI":"10.4103\/ijmm.IJMM_18_107"},{"key":"S002221512100013X_ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-018-3245-3"},{"key":"S002221512100013X_ref28","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt477"},{"key":"S002221512100013X_ref5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006287.pub4"},{"key":"S002221512100013X_ref11","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt128"},{"key":"S002221512100013X_ref22","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199805000-00006"},{"key":"S002221512100013X_ref31","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02176-12"},{"key":"S002221512100013X_ref32","doi-asserted-by":"publisher","DOI":"10.1177\/0022034519863645"},{"key":"S002221512100013X_ref27","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013260"},{"key":"S002221512100013X_ref29","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.20"},{"key":"S002221512100013X_ref23","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1006"},{"key":"S002221512100013X_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2013.05.034"},{"key":"S002221512100013X_ref20","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES2015.20.18.21117"},{"key":"S002221512100013X_ref1","volume-title":"Infections of the Ear Nose, Throat, and Sinuses","author":"Paras","year":"2018"},{"key":"S002221512100013X_ref6","doi-asserted-by":"publisher","DOI":"10.1136\/pmj.78.923.545"}],"container-title":["The Journal of Laryngology &amp; Otology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S002221512100013X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T07:34:58Z","timestamp":1623396898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S002221512100013X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S002221512100013X"],"URL":"https:\/\/doi.org\/10.1017\/s002221512100013x","relation":{},"ISSN":["0022-2151","1748-5460"],"issn-type":[{"value":"0022-2151","type":"print"},{"value":"1748-5460","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}